Key result
Heparan sulfate proteoglycan upregulation in DCM is linked to immune activation, cardiac fibrosis, and HF.
Why the study?
Heparan sulfate forms proteoglycans to perform biological processes in mammals, but its role in dilated cardiomyopathy remains to be explored.
Observational
Answers are grounded in this paper and cite their sources.
Heparan sulfate proteoglycans are upregulated in dilated cardiomyopathy and may serve as biomarkers for a novel molecular classification of the disease.
Objectives: Heparan sulfate (HS) forms heparan sulfate proteoglycans (HSPGs), such as syndecans (SDCs) and glypicans (GPCs), to perform biological processes in the mammals. This study aimed to explore the role of HS in dilated cardiomyopathy (DCM). Methods: Two high throughput RNA sequencing, two microarrays, and one single-cell RNA sequencing dataset of DCM hearts were downloaded from the Gene Expression Omnibus (GEO) database and integrated for bioinformatics analyses. Differential analysis, pathway enrichment, immunocytes infiltration, subtype identification, and single-cell RNA sequencing analysis were used in this study. Results: The expression level of most HSPGs was significantly upregulated in DCM and was closely associated with immune activation, cardiac fibrosis, and heart failure. Syndecan2 (SDC2) was highly associated with collagen I and collagen III in cardiac fibroblasts of DCM hearts. HS biosynthetic pathway was activated, while the only enzyme to hydrolyze HS was downregulated. Based on the expression of HSPGs, patients with DCM were classified into three molecular subtypes, i.e., C1, C2, and C3. Cardiac fibrosis and heart failure were more severe in the C1 subtype. Conclusion: Heparan sulfate is closely associated with immune activation, cardiac fibrosis, and heart failure in DCM. A novel molecular classification of patients with DCM is established based on HSPGs.
No takes yet. Share an insight, caveat, or question.
Song et al. (2022) conducted an observational in Dilated Cardiomyopathy (DCM). Heparan sulfate proteoglycans (HSPGs) expression vs. Normal heart tissues was evaluated on Expression levels of heparan sulfate proteoglycans (HSPGs) and their association with cardiac fibrosis and heart failure. The expression of most heparan sulfate proteoglycans was significantly upregulated in dilated cardiomyopathy and was closely associated with immune activation, cardiac fibrosis, and heart failure.
Synapse has enriched 10 related papers. Consider them for comparative context: